Globus Medical Inc (GMED) P/E ratio history

$81.41

Latest weekly close · Market cap $11.2B

Share GMED P/E history
Historically low

As of

GMED's P/E of 20.9x is lower than 92% of its weekly readings over the last five years.

Weekly P/E with its 5-year range

P/E each weekMiddle half of the last 5 years5-year median 39.9×
P/E weekly history0×100×200×300×20.9×20222023202420252026
5-year median
39.9×
10-year median
37.4×
5-year low to high
17.8×–267.4×
Versus 5-year median
-48%

P/E

8thpercentile

of its weekly readings over the last five years

Historically low

Growth, last 12 months vs the year before

Revenue
+20%accelerating
EPS
+50%

Price vs revenue and EPS, indexed to 100

Each line starts at 100 at its first positive reading over the last five years. Revenue and EPS change at fiscal quarter ends.

PriceRevenue, last 12 monthsEPS, last 12 months100 = first reading
010020030040020222023202420252026

P/E at each year-end

The last weekly reading of each year, and its percentile against the five years before it.

GMED P/E at each year-end
Year-endP/E5-year percentile
28.2×12
127.4×93
34.4×36
49.2×78
39.9×60
70.9×99
40.2×88
28.0×59
37.4×100
20.3×25

Loading peers and related research…

About this history

What is GMED's current P/E?
GMED's P/E of 20.9x is lower than 92% of its weekly readings over the last five years.
What is GMED's five-year median P/E?
39.9x. Half of GMED's weekly readings over the last five years were higher and half were lower. This page has 712 weekly readings, from Mar 4, 2013 to Oct 19, 2026.
Does a low historical rank mean a stock is a buy?
No. The rank compares GMED only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.

Source: SEC company filings and weekly market prices. Multiples use the last twelve months of financial results. Updated .

How the valuation data is built